Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 May;91(5):2126–2132. doi: 10.1172/JCI116437

Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.

B W Walsh 1, F M Sacks 1
PMCID: PMC288213  PMID: 8486779

Abstract

Oral contraceptives (OC) raise plasma triglyceride and VLDL levels, which may be of concern, since some conditions characterized by elevated triglycerides are associated with atherosclerosis. To identify the responsible mechanism, we studied 11 healthy premenopausal women, 5 of whom were taking OC containing 0.035 mg ethinyl estradiol, and 6 of whom were not. Their rates of VLDL and LDL metabolism were measured by endogenously labeling apoB, the protein component of VLDL and LDL, by an intravenous infusion of deuterated leucine. OC use had the greatest effect on the large, triglyceride-rich VLDL subfraction (Sf 60-400), increasing plasma levels threefold and production rates fivefold (P < 0.05). Among OC users, small VLDL (Sf 20-60) levels were 2.2 times higher, and production rates were 3.4-fold higher (P < 0.05). The fractional catabolic rates of large and small VLDL were similar among OC users and nonusers. LDL levels and metabolic rates were not significantly different between the two groups. Thus, contemporary low dose OC substantially raise VLDL levels by increasing the production rate of large, triglyceride-rich VLDL, and not by slowing VLDL catabolism. Since VLDL catabolism is not impaired, we speculate that the hypertriglyceridemia induced by OC may be less atherogenic than that of hypertriglyceridemia resulting from impaired lipolysis. This may explain why long-term OC use does not appear to promote atherosclerosis.

Full text

PDF
2126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angelin B., Einarsson K., Hellström K., Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res. 1978 Nov;19(8):1017–1024. [PubMed] [Google Scholar]
  2. Bachorik P. S., Albers J. J. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 1986;129:78–100. doi: 10.1016/0076-6879(86)29063-1. [DOI] [PubMed] [Google Scholar]
  3. Bersot T. P., Innerarity T. L., Mahley R. W., Havel R. J. Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia. J Clin Invest. 1983 Sep;72(3):1024–1033. doi: 10.1172/JCI111026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brunzell J. D., Schrott H. G., Motulsky A. G., Bierman E. L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism. 1976 Mar;25(3):313–320. doi: 10.1016/0026-0495(76)90089-5. [DOI] [PubMed] [Google Scholar]
  5. Carlson L. A., Böttiger L. E., Ahfeldt P. E. Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand. 1979;206(5):351–360. [PubMed] [Google Scholar]
  6. Cryer D. R., Matsushima T., Marsh J. B., Yudkoff M., Coates P. M., Cortner J. A. Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry. J Lipid Res. 1986 May;27(5):508–516. [PubMed] [Google Scholar]
  7. Gianturco S. H., Bradley W. A., Gotto A. M., Jr, Morrisett J. D., Peavy D. L. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest. 1982 Jul;70(1):168–178. doi: 10.1172/JCI110590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kissebah A. H., Harrigan P., Wynn V. Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm Metab Res. 1973 May;5(3):184–190. doi: 10.1055/s-0028-1093969. [DOI] [PubMed] [Google Scholar]
  10. Moore R. D., Pearson T. A. Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore) 1986 Jul;65(4):242–267. doi: 10.1097/00005792-198607000-00004. [DOI] [PubMed] [Google Scholar]
  11. Packard C. J., Munro A., Lorimer A. R., Gotto A. M., Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest. 1984 Dec;74(6):2178–2192. doi: 10.1172/JCI111644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sacks F. M., Breslow J. L. Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans. Arteriosclerosis. 1987 Jan-Feb;7(1):35–46. doi: 10.1161/01.atv.7.1.35. [DOI] [PubMed] [Google Scholar]
  13. Schaefer E. J., Foster D. M., Zech L. A., Lindgren F. T., Brewer H. B., Jr, Levy R. I. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab. 1983 Aug;57(2):262–267. doi: 10.1210/jcem-57-2-262. [DOI] [PubMed] [Google Scholar]
  14. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
  15. Stampfer M. J., Willett W. C., Colditz G. A., Speizer F. E., Hennekens C. H. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988 Nov 17;319(20):1313–1317. doi: 10.1056/NEJM198811173192004. [DOI] [PubMed] [Google Scholar]
  16. Tall A., Granot E., Brocia R., Tabas I., Hesler C., Williams K., Denke M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest. 1987 Apr;79(4):1217–1225. doi: 10.1172/JCI112940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Taskinen M. R., Nikkilä E. A., Välimäki M., Sane T., Kuusi T., Kesäniemi A., Ylikahri R. Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J. 1987 Feb;113(2 Pt 2):458–464. doi: 10.1016/0002-8703(87)90614-4. [DOI] [PubMed] [Google Scholar]
  18. Wahl P., Walden C., Knopp R., Hoover J., Wallace R., Heiss G., Rifkind B. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med. 1983 Apr 14;308(15):862–867. doi: 10.1056/NEJM198304143081502. [DOI] [PubMed] [Google Scholar]
  19. Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V., Sacks F. M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991 Oct 24;325(17):1196–1204. doi: 10.1056/NEJM199110243251702. [DOI] [PubMed] [Google Scholar]
  20. Warnick G. R. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 1986;129:101–123. doi: 10.1016/0076-6879(86)29064-3. [DOI] [PubMed] [Google Scholar]
  21. Willett W. C., Sampson L., Browne M. L., Stampfer M. J., Rosner B., Hennekens C. H., Speizer F. E. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol. 1988 Jan;127(1):188–199. doi: 10.1093/oxfordjournals.aje.a114780. [DOI] [PubMed] [Google Scholar]
  22. Wolfe B. M., Huff M. W. Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women. J Clin Invest. 1989 Jan;83(1):40–45. doi: 10.1172/JCI113882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. ZILVERSMIT D. B. The design and analysis of isotope experiments. Am J Med. 1960 Nov;29:832–848. doi: 10.1016/0002-9343(60)90117-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES